Qualigen Therapeutics Inc (QLGN)
0.3017
+0.01
(+2.17%)
USD |
NASDAQ |
Apr 23, 16:00
0.3187
+0.02
(+5.63%)
After-Hours: 20:00
Qualigen Therapeutics Gross Profit Margin (Quarterly)
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2023 | 37.52% |
| March 31, 2023 | 21.30% |
| December 31, 2022 | |
| September 30, 2022 | |
| June 30, 2022 | 23.13% |
| March 31, 2022 | -14.79% |
| December 31, 2021 | 17.62% |
| Date | Value |
|---|---|
| September 30, 2021 | 14.02% |
| June 30, 2021 | 18.01% |
| March 31, 2021 | 36.69% |
| September 30, 2020 | -10.00% |
| June 30, 2020 | 10.63% |
| September 30, 2019 | 15.74% |
| June 30, 2019 | 35.28% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
-14.79%
Minimum
Mar 2022
37.52%
Maximum
Jun 2023
17.10%
Average
17.81%
Median
Gross Profit Margin (Quarterly) Benchmarks
| Marizyme Inc | 71.91% |
| CEL-SCI Corp | -- |
| AIM ImmunoTech Inc | 81.54% |
| IGC Pharma Inc | 65.20% |
| NovaBay Pharmaceuticals Inc | 48.70% |